Analysts' Top Healthcare Picks: Opus Genetics (IRD), Elevation Oncology (ELEV)

TipRanksDec 15 23:40 · Ratings

H.C. Wainwright Maintains Elevation Oncology(ELEV.US) With Buy Rating, Maintains Target Price $6

Futu NewsDec 13 19:31 · Ratings

Promising Pipeline and Strategic Advances Support Buy Rating for Elevation Oncology

TipRanksDec 13 19:15 · Ratings

Express News | Synaffix: Co Is Eligible to Receive up to $368 Mln in Upfront and Clinical, Regulatory, and Commercial Milestone Payments

BreakingsDec 12 20:39

Express News | Elevation Oncology Inc: Expects to Present Eo-1022 Preclinical Data in 1H 2025 and to File an Ind Application in 2026

BreakingsDec 12 20:30

Express News | Elevation Oncology Expands Pipeline With Nomination of Eo-1022, a Her3 ADC for the Treatment of Her3-Expressing Solid Tumors

BreakingsDec 12 20:30